MedPath
NMPA Approval

Cefaclor Sustained-Release Tablets

国药准字H20020456

July 12, 2024

Drug Information

头孢克洛缓释片

帅先

帅先

片剂

0.375g(按C₁₅H₁₄ClN₃O₄S计)

化学药品

July 12, 2024

Company Information

Applicant Company

浙江省嵊州市嵊州大道北1000号

Manufacturing Company

绍兴嵊州市嵊州大道北1000号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.